Saisheng Pharmaceutical: It is expected that the net profit will be between 13,773,700 yuan and 20,000,000 yuan in 2025.

Sai Sheng Pharmaceutical announced that it is expected to turn a profit in 2025, with a net profit attributable to shareholders of the company of 13.7737 to 20 million yuan, compared to -68.8531 million yuan in the same period last year. It is expected that the net profit after deducting non-recurring gains and losses will be -28.6864 to -23.4707 million yuan, a decrease of 299.58% to 343.93% from the same period last year. The main reason for this is that during the reporting period, the company's financial assets fair value changes and the income from investments in associated enterprises increased compared to the previous period. The financial assets invested by the company are mainly in biopharmaceuticals, medical devices, and other companies related to the company's main business, as well as pharmaceutical and health professional investment funds. In this reporting period, the fair value change income and the income from investments in associated enterprises were approximately 19 million yuan, an increase of about 110%.